A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma

Endocrine-Related Cancer

Volumn 13, Issue 2, 2006, Pages 525-533

  Cecchin, D ^a   Lumachi, F ^a   Marzola, M C ^a   Opocher, G ^a   Scaroni, C ^a   Zucchetta, P ^a   Mantero, F ^a   Bui, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131;

ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; SCINTIGRAPHY; SCORING SYSTEM; VON HIPPEL LINDAU DISEASE;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 33745068054     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01066     Document Type: Article

References (27)

1. Babington CKY, Tony KLL, Tse TW, Tsang MW & Chan JCS 2000 Sporadic bilateral adrenal medullary hyperplasia: apparent false positive MIBG scan and expected MRI findings. European Journal of Radiology 36 28-31.
2. Berglund AS, Hulthen UL, Manhem P, Thorsson O, Wollmer P & Tornquist C 2001 Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. Journal of Internal Medicine 249 247-251.
3. 132I as sodium iodide. Journal of Nuclear Medicine 16 857-860.
4. Bomanji J, Levison DA, Flatman WD, Horne T, Bouloux PMG, Ross G, Britton KE & Besser GM 1987 Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. Journal of Nuclear Medicine 28 973-978.
5. De Graaf JS, Dullaart RP, Kok T, Piers DA & Zwierstra RP 2000 Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. European Journal of Surgery 166 289-292.
6. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS & Keiser HR 1999 Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine 340 1872-1879.
7. Elgazzar AH, Gelfand MJ, Washburn LC, Clark J, Nagaraj N, Cummings D, Hughes J & Maxon HR 3rd 1995 I-123 MIBG scintigraphy in adults. A report of clinical experience. Clinical Nuclear Medicine 20 147-152.
8. Freitas JE 1995 Adrenal cortical and medullary imaging. Seminars in Nuclear Medicine 25 235-250.
9. Furuta N, Kiyota H, Yoshigoe F, Hasegawa N & Ohishi Y 1999 Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy. International Journal of Urology 6 119-124.
10. Goldstein DS, Eisenhofer G, Flynn JA, Wand G & Pacak K 2004 Diagnosis and localization of pheochromocytoma. Hypertension 43 907-910.
11. Hanson WH, Feldman JM, Beam CA, Leight GS & Coleman RE 1991 Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma. Archives of Internal Medicine 151 1397-1402.
12. Lenders JWM, Eisenhofer G, Mannelli M & Pacak K 2005 Phaeochromocytoma. Lancet 366 665-675.
13. Lindbery S, Fjalling M, Jacobsson L, Jansson S & Tisell LE 1988 Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG. Journal of Nuclear Medicine 29 1638-1643.
14. Mannelli M, Ianni L, Cilotti A & Conti A 1999 Pheochromocytoma in Italy: a multicentric retrospective study. European Journal of Endocrinology 141 619-624.
15. Maurea S, Cuocolo A, Reynolds JC, Tumeh SS, Begley MG, Linehan WM, Norton JA, Walther MM, Keiser HR & Neumann RD 1993 Iodine-131- metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. Journal of Nuclear Medicine 34 173-179.
16. Maurea S, Lastoria S, Cuocolo A, Celentano L & Salvatore M 1995 The diagnosis of nonfunctioning pheochromocytoma. The role of I-123 MIBG imaging. Clinical Nuclear Medicine 20 22-24.
17. Maurea S, Cuocolo A, Reynolds JC, Neumann RD & Salvatore M 1996 Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Quarterly Journal of Nuclear Medicine 40 365-371.
18. Murgia A, Martella M, Vinanzi C, Polli R, Perilongo G & Opocher G 2000 Somatic mosaicism in von Hippel-Lindau Disease. Human Mutation 15 114.
19. Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC & Beierwaltes WH 1983 The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. Journal of Nuclear Medicine 24 672-682.
20. Pacak K, Goldstein DS, Doppman JL, Shulkin BL, Udelsman R & Eisenhofer G 2001 A 'pheo' lurks: novel approaches for locating occult pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 86 3641-3646.
21. Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J & Gwidlet J 1990 A radiopharmaceuticals schedule for imaging in paediatrics. Task Group European Association of Nuclear Medicine. European Journal of Nuclear Medicine 17 127-129.
22. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J & Beierwalters WH 1985 Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. Journal of Nuclear Medicine 26 576-585.
23. Shapiro B, Sisson JC, Shulkin BL, Gross MD & Zempel S 1995 The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors. Quarterly Journal of Nuclear Medicine 39 3-8.
24. Shapiro B, Gross MD & Shulkin B 2001 Radioisotope diagnosis and therapy of malignant pheochromocytoma. Trends in Endocrinology and Metabolism 12 469-475.
25. Taïeb D, Sebag F, Hubbard JG, Mundler O, Henry JF & Conte-Devolx B 2004 Does iodine-131 metaiodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Clinical Endocrinology 61 102-108.
26. Van Gils AP, van Erkel AR, Falke TH & Pauwels EK 1994 Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities. European Journal of Nuclear Medicine 21 239-253.
27. Werbel SS & Ober KP 1995 Pheochromocytoma. Update on diagnosis, localization, and management. Medical Clinics of North America 79 131-153.